Needles have the least research
NAD Injection and IV NAD+ have the weakest proof
You’ll see what remained in sampled blood, the complaints reported during an IV, and why the FDA recalled a mixed shot.
IV NAD+ left the blood fast in one small study
Here’s the bottom line. Research on shots and IV drips is very thin. Pharmacies mix these products, and the FDA hasn’t approved them. One small study found almost no unchanged NAD+ in blood once the drip began, but it didn’t track where the NAD+ went or show that body tissue used it at all. That’s all the test proved. The FDA recalled one mixed shot after bacteria left dangerous waste in it. That’s a real quality risk. Clinics often use an IV; some give a shot under the skin. We don’t sell either one. We tell you what the reports can and can’t show.
A NAD injection uses a vein or a shot under skin
A NAD injection puts NAD+ into your body through a needle. A clinic may run it into a vein as an IV. Some clinics instead use a pharmacy-mixed shot beneath the skin or in muscle. This comes from clinic reports, not a controlled test. Pills work another way. Your body changes NR or NMN before making NAD+. A shot tries to put NAD+ itself into your blood. This pharmacy-mixed product lacks FDA approval. Few sound studies tracked what happened next.
The sales pitch sounds easy: NAD+ falls with age, so replace it [5]. Your body doesn’t work that neatly. NAD+ can break apart outside cells. Cells may take in very little whole NAD+. A drip can’t be assumed to refill the supply inside your tissue.
IV NAD+ therapy rests on small, weak reports
IV NAD+ therapy, also called NAD IV therapy, is sold far ahead of the facts. The studies are few. Some used very small groups. Others looked back at old clinic notes. Neither kind gives strong proof. One small study found almost no unchanged NAD+ in sampled blood during the drip’s first two hours. After those two hours, the reading for unchanged NAD+ began to rise. Researchers didn’t learn whether anyone became healthier. A separate look at clinic notes found more stomach trouble with IV NAD+ than IV NR. NAD+ drips also took longer. Clinic notes aren’t a controlled trial.
Some reports used drips lasting several hours or repeated them over days. They tell you what was tried, not what’s right for you. No report found a health improvement that lasted. Needles have the least good proof of all the forms studied.
NAD+ half life means how fast half leaves blood
Half life means the time it takes for half the NAD+ to leave your blood. There isn’t one clear answer for your whole body. Most cells don’t take in whole NAD+ with ease. One small IV test found that nearly all unchanged NAD+ was gone from sampled blood during the first two hours. The test didn’t track where it went. The test also didn’t show that the drop caused discomfort. No large trial measured that risk. Small clinic reports linked faster drips with more complaints, but they don’t give a firm people count.
NR pills act more slowly. In 8–12 week trials, blood readings climbed over time and stayed high during use. One trial lasted 8 weeks. The rises were 22%/51%/142% at 100/300/1000 milligrams a day [4]. An IV and an NR pill don’t act alike. Neither blood result proves better health.
The FDA recalled one NAD+ shot over a serious risk
The quality risk is real. The recall was Class I, the FDA’s highest-risk group. Tests found too much dangerous waste left by bacteria. The FDA recall record, not a treatment trial, supports that warning. Warmth and damp air can also harm mixed NAD+. Product reports say a prepared shot has to be kept cold and out of light.
A shot skips many of your body’s normal barriers. A tainted shot brings a different risk from a swallowed pill. The recall doesn’t mean every mixed NAD+ product is bad. Poor mixing or storage can still harm you.
Fast IV drips brought chest and stomach trouble
People reported chest pressure, chest tightness, stomach pain, flushing, and nausea. Small clinic reports linked the complaints with fast IV NAD+. One review looked back at old clinic notes. In those notes, the problems cleared when the IV ended and didn’t last past the visit. Slower drips brought fewer complaints. No large trial confirmed that finding or gave a firm count of people. The old notes aren’t a safety guide for you.